PAREXEL International

The CenterWatch Monthly, January 2013

Wednesday, January 2, 2013 01:39 PM

Parexel celebrates 30 years of change, growth

More... »

Parexel acquires Liquent

Wednesday, January 2, 2013 09:49 AM

Parexel International has acquired all of the outstanding equity securities of Liquent, a global provider of Regulatory Information Management (RIM) solutions. Liquent provides an integrated platform of software solutions for regulatory submissions and product registration management, as well as a range of complementary business process outsourcing capabilities.

More... »

Perceptive Informatics opens first customer care office in China

Monday, December 10, 2012 10:46 AM

Perceptive Informatics, an e-Clinical solutions provider and subsidiary of PAREXEL International, has opened a customer care office in Shanghai to service biopharmaceutical researchers in China and Taiwan who are using Perceptive’s technology solutions.

More... »

PAREXEL, NTUH to support clinical research in Taiwan

Monday, December 3, 2012 12:17 PM

PAREXEL International, a global biopharmaceutical services provider, and the National Taiwan University Hospital (NTUH) have established a collaboration to provide drug development services in Taiwan.

More... »

PAREXEL International announces CFO transition

Friday, August 10, 2012 02:11 PM

PAREXEL International, a global bio/pharmaceutical services organization, announced that James F. Winschel, Jr., senior vice president and CFO, will transition to the position of executive vice president at PAREXEL upon appointment of a new CFO. 

More... »

PAREXEL appoints Larson as VP of evidence development

Friday, August 3, 2012 12:25 PM

PAREXEL Consulting, a business unit of PAREXEL International and a global consultancy serving the biopharmaceutical and medical device industries, has appointed Leanne R. Larson as vice president of evidence development, a newly created position.

More... »

PAREXEL launches BioPharm Unit to serve smaller sponsors

Wednesday, July 25, 2012 09:28 AM

Boston-based CRO PAREXEL International has launched the PAREXEL BioPharm Unit, a dedicated unit focused solely on the needs of small and mid-sized biopharmaceutical companies to help achieve their development goals.

More... »

PAREXEL partners with Korea Drug Development Fund

Thursday, July 19, 2012 02:29 PM

Boston-based CRO PAREXEL International announced it is the first CRO chosen by the Korea Drug Development Fund (KDDF) to help Korean companies develop and commercialize healthcare products for the global market.

More... »

Parexel launches Parexel MyTrials fully-integrated eClinical platform

Monday, June 18, 2012 10:14 AM

Parexel International, a global biopharmaceutical services provider based in Boston, Mass., has launched the Parexel MyTrials platform, a fully-integrated eClinical solution that simplifies the clinical trial process.

More... »

Parexel releases quarterly financial results

Wednesday, May 2, 2012 09:56 AM

Global CRO Parexel International has released its financial results for the third quarter ended March 31, 2012.

More... »